Rivaroxaban for the treatment of deep vein thrombosis and prevention of recurrent deep vein thrombosis and pulmonary embolism

NICE technology appraisals [TA261] Published date:

NICE recommends rivaroxaban as a possible treatment for adults with deep vein thrombosis, and to help prevent a pulmonary embolism or another deep vein thrombosis.

Why has NICE said this?

NICE looks at how well treatments work, and also at how well they work in relation to how much they cost the NHS. NICE recommended rivaroxaban because it works better than other treatments available on the NHS. In the short term, it is cheaper than other treatments. For longer-term treatment rivaroxaban costs more than other treatments, but this is justified by the benefits it provides.

Get involved